{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:34:58Z","timestamp":1774121698219,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.cgh.2009.07.012","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T07:09:12Z","timestamp":1248332952000},"page":"1355-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Piotr","family":"Milkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayman","family":"Buwaneswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Coltescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakera","family":"Shums","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jenny","family":"Heathcote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2009.07.012_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00004836-200310000-00011","article-title":"Autoantibodies in the diagnosis and management of liver disease","volume":"37","author":"Czaja","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2009.07.012_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cgh.2009.07.012_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1089-3261(03)00096-5","article-title":"Pathogenesis of primary biliary cirrhosis","volume":"7","author":"Kita","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2009.07.012_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cgh.2009.07.012_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhep.2001.26514","article-title":"Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens","volume":"34","author":"Miyakawa","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u201cTrue\u201d antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cgh.2009.07.012_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-3083.1992.tb03224.x","article-title":"Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution","volume":"36","author":"Szostecki","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cgh.2009.07.012_bib8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.510230512","article-title":"Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis","volume":"23","author":"Bandin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib9","first-page":"495","article-title":"Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope","volume":"21","author":"Tartakovsky","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.178.6.2237","article-title":"Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210","volume":"178","author":"Nickowitz","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.cgh.2009.07.012_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2009.07.012_bib12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2009.07.012_bib14","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2009.07.012_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2009.07.012_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2009.07.012_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2009.07.012_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2009.07.012_bib22","first-page":"S412","article-title":"Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis","volume":"37","author":"Nakamura","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2009.07.012_bib23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1023\/A:1024748714580","article-title":"Frequency and significance of antibodies to chromatin in autoimmune hepatitis","volume":"48","author":"Czaja","year":"2003","journal-title":"Dig Dis Sci"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356509006685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356509006685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:53Z","timestamp":1761541553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356509006685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1542356509006685"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2009.07.012","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2009.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}